RIGGS RORY B — SEC Form 4 filings

SEC reporting owner CIK 1016835. 19 Form 4 filings on record with FilingPulse; latest filed 2026-06-04.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2024-02-22 to 2026-06-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Intra-Cellular Therapies, Inc. (ITCI)Director91 leg · 4,462 sh · $337,19323
Cibus, Inc. (CBUS)Director916
Royalty Pharma plc (RPRX)Director12

Form 4 filings — RIGGS RORY B

FiledFormIssuerReported transactionsSource
2026-06-044Cibus, Inc. (CBUS)Grant/award (A): 77,586 (derivative) @ $0EDGAR
2026-02-024Cibus, Inc. (CBUS)Grant/award (A): 333,333 @ $1.50EDGAR
2025-06-114Cibus, Inc. (CBUS)Option exercise/expiry (X): 4,000,000 @ $0.00 · Option exercise/expiry (X): 50,000 @ $0.01 · Option exercise/expiry (X): 4,000,000 (derivative) @ $0 · Option exercise/expiry (X): 50,000 (derivative) @ $0EDGAR
2025-06-104Cibus, Inc. (CBUS)Grant/award (A): 5,714,286 @ $1.75EDGAR
2025-05-274Cibus, Inc. (CBUS)Grant/award (A): 39,301 (derivative) @ $0EDGAR
2025-04-024Intra-Cellular Therapies, Inc. (ITCI)Disposition to issuer (D): 131,512 @ $132 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 16,757 (derivative) · +3 moreEDGAR
2025-01-234Cibus, Inc. (CBUS)Grant/award (A): 4,000,000 (derivative) · Grant/award (A): 4,000,000 (derivative) @ $2.50EDGAR
2025-01-104Cibus, Inc. (CBUS)Conversion (C): 1,388,084 · Conversion (C): 1,388,084 · Conversion (C): 1,388,084 (derivative)EDGAR
2025-01-034Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 215 @ $83.52EDGAR
2024-10-154Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 14,189 · Option exercise (M): 14,189 (derivative) @ $0EDGAR
2024-10-024Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 246 @ $73.17EDGAR
2024-09-204Cibus, Inc. (CBUS)Grant/award (A): 250,000 @ $4EDGAR
2024-07-024Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 262 @ $68.49EDGAR
2024-06-254Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 1,567 · Option exercise (M): 20,000 @ $16.86 · Sale (S): 4,462 @ $75.57 · Option exercise (M): 1,567 (derivative) @ $0 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2024-06-184Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 2,951 (derivative) @ $0 · Grant/award (A): 4,322 (derivative) @ $0EDGAR
2024-06-144Cibus, Inc. (CBUS)Grant/award (A): 98,040 @ $10.20 · Grant/award (A): 98,040 (derivative)EDGAR
2024-04-024Intra-Cellular Therapies, Inc. (ITCI)Grant/award (A): 260 @ $69.20EDGAR
2024-03-224Intra-Cellular Therapies, Inc. (ITCI)Option exercise (M): 20,000 @ $18.56 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2024-02-224Royalty Pharma plc (RPRX)Conversion (C): 300,000 @ $0 · Conversion (C): 30,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1016835 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →